|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||||||||||
| Cash and due from banks | |||||||||||||||||||
| Short-term investments | |||||||||||||||||||
| Interest-bearing time deposits | |||||||||||||||||||
| Total cash and cash equivalents | |||||||||||||||||||
| Interest-earning time deposits | |||||||||||||||||||
| Investments in available-for-sale securities at fair value | |||||||||||||||||||
| Investments in held-to-maturity securities, at amortized cost (fair values of $63,355 at March 31, 2025 and $67,505 at December 31, 2024) | |||||||||||||||||||
| Loans, net of allowance for credit losses of $8,670 at March 31, 2024 (unaudited) and $8,591 at December 31, 2023 | |||||||||||||||||||
| Investments in available-for-sale securities, at fair value | |||||||||||||||||||
| Investments in held-to-maturity securities, at amortized cost (fair values of $38,674 as of September 30, 2026, and $52,326 at December 31, 2025) | |||||||||||||||||||
| Loans held-for-sale | |||||||||||||||||||
| Loans, net of allowance for credit losses of $8,808 at March 31, 2025 and $8,884 at December 31, 2024 | |||||||||||||||||||
| Loans, net of allowance for credit losses of $10,330 at September 30, 2026, and $10,255 at December 31, 2025 | |||||||||||||||||||
| Federal Home Loan Bank stock, at cost | |||||||||||||||||||
| Premises and equipment, net | |||||||||||||||||||
| Accrued interest receivable | |||||||||||||||||||
| Deferred tax asset, net | |||||||||||||||||||
| Bank-owned life insurance | |||||||||||||||||||
| Other assets | |||||||||||||||||||
| Total assets | |||||||||||||||||||
| LIABILITIES AND SHAREHOLDERS' EQUITY | |||||||||||||||||||
| Noninterest-bearing | |||||||||||||||||||
| Interest-bearing | |||||||||||||||||||
| Total deposits | |||||||||||||||||||
| Federal Home Loan Bank advances | |||||||||||||||||||
| Other liabilities | |||||||||||||||||||
| Total liabilities | |||||||||||||||||||
| Shareholders' equity: | |||||||||||||||||||
| Preferred Stock, par value $0.01; Authorized: 1,000,000 shares; No shares issued | |||||||||||||||||||
| Common Stock, par value $0.01; Authorized: 30,000,000 shares; Issued and outstanding: 8,737,641 shares and 8,792,719 shares at September 30, 2026 and December 31, 2025, respectively | |||||||||||||||||||
| Additional paid-in capital | |||||||||||||||||||
| Retained earnings | |||||||||||||||||||
| Accumulated other comprehensive income (loss) | |||||||||||||||||||
| Unallocated common shares held by the Employee Stock Ownership Plan | |||||||||||||||||||
| Total shareholders' equity | |||||||||||||||||||
| Total liabilities and shareholders' equity | |||||||||||||||||||
Loading...